Prostaglandin E2 cooperates with TRANCE in osteoclast induction from hemopoietic precursors: Synergistic activation of differentiation, cell spreading, and fusion

Endocrinology

Volumn 140, Issue 4, 1999, Pages 1927-1935

  Wani, Mohan R ^a   Fuller, Karen ^a   Kim, Nack Sung ^a,b   Choi, Yongwon ^a,b,c   Chambers, Tim J ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b ROCKEFELLER UNIVERSITY   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR; ACID PHOSPHATASE; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CD40 LIGAND; ISOENZYME; MEMBRANE PROTEIN; TARTRATE-RESISTANT ACID PHOSPHATASE;

ANIMAL CELL; ARTICLE; BONE METABOLISM; CELL DIFFERENTIATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; ANIMAL; BONE MARROW CELL; CELL COUNT; CELL CULTURE; CELL FUSION; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; KINETICS; MONONUCLEAR CELL; SPLEEN;

ACID PHOSPHATASE; ANIMALS; BONE MARROW CELLS; BONE RESORPTION; CD40 LIGAND; CELL COUNT; CELL DIFFERENTIATION; CELL FUSION; CELLS, CULTURED; DINOPROSTONE; DRUG SYNERGISM; HEMATOPOIETIC STEM CELLS; ISOENZYMES; KINETICS; LEUKOCYTES, MONONUCLEAR; MEMBRANE GLYCOPROTEINS; MICE; OSTEOCLASTS; SPLEEN;

EID: 0032586714     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.4.6647     Document Type: Article

References (45)

1. 1. Wong BR, Josien R, Lee SY, Sauter B, Li H-L, Steinman RM, Choi Y 1997 TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J Exp Med 186:2075-2080
2. 2. Wong BR, Rho J, Arron J, Robinson E, Orlinick J, Chao M, Kalachikov S, Cayani E, Bartlett III FS, Frankel WN, Lee SY, Choi Y 1997 TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J Biol Chem 272:25190-25194
3. 3. Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, Roux ER, Teepe MC, DuBose RF, Cosman D, Galibert L 1997 A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390:175-179
4. 4. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S-I, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T 1998 Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and identical to TRANCE-RANKL. Proc Natl Acad Sci USA 95:3597-3602
5. 5. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess TER, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ 1998 Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176
6. 6. Fuller K, Wong B, Fox S, Choi Y, Chambers TJ 1998 TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J Exp Med 188:138-142
7. 7. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang M-S, Lüthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Columbero A, Tan H-L, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Program AE, Boyle WJ 1997 Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309-319
8. 8. Klein DC, Raisz LG 1970 Prostaglandins: stimulation of bone resorption in tissue culture. Endocrinology 86:1436-1440
9. 9. Raisz LG 1982 Prostaglandins and skeletal metabolism. In: Lee JB (ed) Prostaglandins. Elsevier, New York, pp 351-372
10. 10. Shinar DM, Rodan GA 1990 Biphasic effects of transforming growth factor β on the production of osteoclast-like cells in mouse bone marrow cultures: the role of prostaglandins in the generation of these cells. Endocrinology 126:3153-3158
11. 2α, on osteoclast formation in mouse bone marrow cultures. J Bone Miner Res 6:157-164
12. 12. Akatsu T, Takahashi N, Debari K, Morita I, Murota S, Nagata N, Takatani O, Suda T 1989 Prostaglandins promote osteoclast like cell formation by a mechanism involving cyclic adenosine 3',5'-monophosphate in mouse bone marrow cell cultures. J Bone Miner Res 4:29-35
13. 13. Tashjian Jr AH, Hohmann EL, Antoniades HN, Levine L 1982 Platelet-derived growth factor stimulates bone resorption via a prostaglandin-mediated mechanism. Endocrinology 111:118-124
14. 14. Tashjian Jr AH, Voelkel EF, Lazzaro M, Singer FR, Roberts AB, Derynck R, Winkler ME, Levine L 1985 α and β human transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria. Proc Natl Acad Sci USA 82:4535-4538
15. 15. Tashjian Jr AH, Voelkel EF, Lazzaro M, Goad D, Bosma T, Levine L 1987 Tumor necrosis factor-α (cachectin) stimulates bone resorption in mouse calvaria via a prostaglandin mediated mechanism. Endocrinology 120:2029-2036
16. 16. Tashjian Jr AH, Levine L 1978 Epidermal growth factor stimulates prostaglandin production and bone resorption in cultured mouse calvariae. Biochem Biophys Res Commun 85:966-975
17. 17. Williams TJ, Morley J 1973 Prostaglandins as potentiators of increased vascular permeability in inflammation. Nature 246:215-217
18. 18. Moncada S, Ferreria SH, Vane JR 1973 Prostaglandins, aspirin-like drugs and the oedema of inflammation. Nature 246:217-219
19. 2 and tumor necrosis factor α cooperate to activate human dendritic cells: synergistic activation of interleukin 12 production. J Exp Med 186:1603-1608
20. 20. Chambers TJ, McSheehy PMJ, Thomson BM, Fuller K 1985 The effect of calcium-regulating hormones and prostaglandins on bone resorption by osteoclasts disaggregated from neonatal rabbit bones. Endocrinology 116:234-239
21. 21. Owens JM, Gallagher AC, Chambers TJ 1996 IL-10 modulates formation of osteoclasts in murine hemopoietic cultures. J Immunol 157:936-940
22. btsA58 transgenic mouse. Proc Natl Acad Sci USA 90:5578-5582
23. 23. Fuller K, Owens JM, Jagger CJ, Wilson A, Moss R, Chambers TJ 1993 Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts. J Exp Med 178:1733-1744
24. 24. Hattersley G, Chambers TJ 1989 Calcitonin receptors as markers for osteoclastic differentiation: correlation between generation of bone-resorptive cells and cells that express calcitonin receptors in mouse bone marrow cultures. Endocrinology 125:1606-1612
25. 131I labelled human growth hormone of high specific activity. Nature 194:495
26. 26. Burstone MS 1958 Histochemical demonstration of acid phosphatases with naphthol AS-phosphate. J Natl Cancer Inst 21:423-539
27. 27. Kurland J, Moore MAS 1977 Modulation of hemopoieses by prostaglandins. Exp Hematol 5:357-373
28. 28. Taetle R, Koessler A 1980 Effects of cyclic nucleotides and prostaglandins on normal and abnormal human myeloid progenitor proliferation. Cancer Res 40:1223-1229
29. 1. Blood Cells 6:701-718
30. 30. Williams N 1979 Preferential inhibition of murine macrophage colony formation by prostaglandin E. Blood 53:1089-1094
31. 1 reversibly induces morphological changes in macrophages and inhibits phagocytosis. Exp Cell Res 119:365-371
32. 32. Hattersley G, Chambers TJ 1990 Effects of interleukin 3 and of granulocyte-macrophage and macrophage colony stimulating factors on osteoclast differentiation from mouse hemopoietic tissue. J Cell Physiol 142:201-209
33. 33. Raisz LG 1996 Interaction of local and systemic factors in the pathogenesis of osteoporosis. In: Marcus R, Feldman D, Kelsey J (eds) Osteoporosis. Academic Press, San Diego, pp 661-670
34. 34. Chambers TJ 1992 Regulation of osteoclast development and function. In: Rifkin BR, Gay CV (eds) Biology and Physiology of the Osteoclast. CRC Press, Boca Raton, pp 105-128
35. 35. Suda T, Takahashi N, Martin TJ 1992 Modulation of osteoclast differentiation. Endocr Rev 13:66-79
36. 36. Warshawsky J, Goltzman D, Rouleau MF, Bergeron JJM 1980 Direct in-vivo demonstration by autoradiography of specific binding sites for calcitonin in skeletal and renal tissues of the rat. J Cell Biol 85:682-694
37. 37. Nicholson GC, Moseley JM, Sexton FM, Mendelsohn FAO, Martin TJ 1986 Abundant calcitonin receptors in isolated rat osteoclasts. J Clin Invest 78:355-360
38. 38. Kaye M 1984 When is it an osteoclast? J Clin Pathol 37:398-400
39. 39. Hattersley G, Chambers TJ 1989 Generation of osteoclastic function in mouse bone marrow cultures: multinuclearity and tartrate-resistant acid phosphatase are unreliable markers for osteoclastic differentiation. Endocrinology 124:1689-1696
40. 40. Lorenz JJ, Furdon PJ, Taylor JD, Verghese MW, Chandra G, Kost TA, Haneline SA, Roner LA, Gray JG 1995 A cyclic adenosine 3',5'-monophosphate signal is required for the induction of IL-1β by TNF-α in human monocytes. J Immunol 155:836-844
41. 41. Chambers TJ, Dunn CJ 1983 Pharmacological control of osteoclastic motility. Calcif Tissue Int 35:566-570
42. 42. Suzuki H, Nakamura I, Takahashi N, Ikuhara T, Matsuzaki K, Isogai Y, Hori M, Suda T 1996 Calcitonin-induced changes in the cytoskeleton are mediated by a signal pathway associated with protein kinase A in osteoclasts. Endocrinology 137:4685-4690
43. 43. Gordon J, Tiller E, Roberts J, Kato K 1993 A community effect in muscle development. Curr Biol 3:1-11
44. 44. Smith WL, Borgeat P 1985 The eicosanoids: prostaglandins, thromboxanes, leukotrienes, and hydroxyeicosaenoic acids. In: Vance DE, Vance JE (ed) Biochemistry of Lipids and Membranes. Benjamin-Cummings, Menlo Park, pp 325-360
45. 45. Jimi E, Shuto T, Koga T 1995 Macrophage colony-stimulating factor and interleukin-1α maintain the survival of osteoclast-like cells. Endocrinology 136:808-811